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Mr. ATOD’s Wild Ride: What Do Alcohol, 
Tobacco, and Other Drugs Have in Common?
David T. Courtwright
Abstract. All researchers agree that individuals can become intoxicated by 
and dependent on alcohol, tobacco, and other psychoactive drugs. But they 
have disagreed over whether, and to what extent, drug pathologies comprise 
a unitary medical problem. Most critically, does addiction have a biological 
common denominator? Consensus on this question has shifted back and 
forth. In the late nineteenth and early twentieth centuries, physicians often 
studied and treated various drug addictions together, working under the 
“inebriety” paradigm. By the mid-twentieth century the inebriety paradigm 
had collapsed. Tobacco and alcohol had split off, both in the medical research 
community and in western popular culture. This article argues that neuro-
scientific, genetic, epidemiological, and historical evidence helped to reunify 
the addiction field in the late twentieth century. A new unifying paradigm 
emerged, variously called chemical dependency, substance abuse, or simply 
ATOD—alcohol, tobacco, and other drugs.
When you write global drug history, you quickly discover 
the limits of your knowledge, and you rely on the work of others. 
Many of the scholars whose research has guided and inspired me are 
present this evening. I first want to express my debt to you and my 
gratitude for the opportunity to address you. I am truly honored.
 My title, “Mr. ATOD’s Wild Ride,” is an anagrammatic play on 
a celebrated episode from Kenneth Grahame’s The Wind in the 
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Willows. Mr. Toad, you will recall, has a thing for fast machines. He 
is, in fact, unable to control himself around them. They “intoxicate 
. . . his weak brain.” Disguised as a washerwoman, Toad comman-
deers a motor car and goes hurtling down the road. When its owner 
and chauffeur imprudently try to stop him, he sends the car veering 
across the road, smashes into a hedge, and goes flying through the 
air.
Mr. Toad’s wild ride has inspired a Monty Python movie and 
an amusement-park ride in my home state of Florida. Toad’s ride 
has also inspired me by suggesting a metaphor for shifting western 
and, more particularly, Anglo-American, attitudes toward ATOD: 
alcohol, tobacco, and other drugs. In the last century those attitudes 
have, like Toad’s car, veered sharply. They have gone from a 
tendency to see ATOD and their pathologies as linked phenomena, 
then to a tendency to see them as separate phenomena, then, in the 
last thirty years, to see them again as linked. I’ve sketched these 
shifting attitudes toward ATOD as a pendular timeline (Figure 1). 
It’s not an exact timeline, for most of the events depicted occurred 
over many years, rather than during a single year. But it makes the 
point. Consensus on this question has lurched from one side of 
history’s road to the other and then back again.
I use the words “tendency” and “consensus.” I don’t think that 
all experts shared these attitudes at any given point in time, or that 
the swings of opinion occurred without dissent. What I propose 
is a sketch of “governing ideas.” Governing ideas are “cognitive 
bundles” of related concepts that have had “considerable intellec-
tual appeal and at some point succeeded in capturing the attention, 
imagination, and actions of the broad population” (Gerstein and 
Harwood 1990, 42). Specialists framed problems in certain ways, 
and their views percolated into popular consciousness and language. 
In the 1960s continental drift and plate tectonics triumphed as 
governing ideas in geology, and before long school children were 
getting watered-down versions in their earth science lessons. New 
ideas about the nature and management of compulsive alcohol 
and other drug use spread in comparable fashion—with, as Sarah 
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Tracy points out, input from patients and their families along the 
way (Tracy 2005).
So what were the governing ideas about psychoactive substances? 
In the late nineteenth century, the key medical concept, at least in 
Britain and most of North America, was inebriety. Many physi-
Figure 1. Governing Ideas about Alcohol, Tobacco, and Other Drugs
   The Social History of Alcohol and Drugs 20 (2005)108
cians who treated alcoholics and narcotic addicts held that these 
conditions were manifestations of a more general mental disorder 
called “inebriety.” The Keeley Institute, a large treatment franchise, 
advertised that the “person addicted to liquor or drugs is a victim 
of a ravishing disease,” which may nevertheless be successfully 
treated “by the famous Keeley Treatment” (Keeley Institute 1921, 
emphasis added). The treatment regimen for residential Keeley 
patients—who might be dependent on alcohol, or narcotics, or 
both—required abstention from tobacco and even caffeinated 
beverages, understood as insalubrious habits likely to trigger 
relapse (White 1998, 55).
The inebriety theory drew on three other popular nineteenth-
century medical ideas. These were neurasthenia, or nervous 
weakness; diathesis, or constitutional predisposition to chronic 
disease; and degeneration, or transmission of morbid deviations 
across generations. Thomas Crothers, a representative figure, taught 
that alcohol and other drugs had pathological effects on the nervous 
system. The effects varied. Those suffering from neurasthenia, such 
as exhausted “brain workers,” were particularly susceptible. Also 
susceptible were those born with a nervous diathesis. Whether 
the vulnerability was environmental or constitutional—in our 
terms, whether it was due to stress, genes, or both—alcohol and 
other drugs left a permanent pathological impression on inebri-
ates’ nerves. The repeated administration of a drug intensified this 
impression into a “morbid craving,” the heedless, self-destructive 
pursuit of the substance that seemed the common denominator of 
all inebriate behavior (Crothers 1902).
Once acquired, the trait of inebriety could be passed on as degen-
erate constitutional tendencies. The process was often one of sinister 
transmogrification. The drunkard’s child might be an opium addict, 
his grandchild an epileptic, his great grandchild a congenital idiot. 
Though inebriate degeneration might assume many forms, its final 
end was always ruin. It was crucial, therefore, to keep the young 
from acquiring inebriate habits, for their sake and for posterity’s. 
Drugs were literally “germ poisons” that threatened the “race” by 
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corrupting sperm and ova. Caleb Saleeby, a prominent English 
eugenicist and opponent of both tobacco and alcohol, went so far 
as to argue that alcoholics should be prevented from procreating 
(Armstrong 2003, 27-42; Woiak 1998). 
Other temperance advocates concentrated on preventing drug 
use from spreading within, rather than across, generations. They 
made tobacco a particular target, for tobacco often led to drink and 
other drugs. The most trenchant of the early “gateway” theorists 
was Charles Towns, a lay addiction specialist. Except for a few 
women, Towns wrote, every alcoholic and addict he treated had a 
history of excessive tobacco use. Smoking magnified any personal 
predisposition toward inebriety, “because the action of tobacco 
makes it normal . . . to feel the need of stimulation.” Tobacco’s irri-
tating effects could be blunted by alcohol, on which the smoker in 
turn became dependent. Then came narcotics to allay hangover and 
other effects of drinking. “Cigarettes, drink, opium is the logical 
and regular series” (Towns 1915, 153).
Towns set forth his views in Habits That Handicap (1915), a slender 
little book that was perhaps the most prescient work about ATOD 
linkages to appear in the early twentieth century. Towns was an 
intuitive sociologist who saw that smoking was socially conducive 
to other forms of addiction. Boys sought out the back rooms of 
pool halls and saloons to smoke in secrecy, and there they also 
learned to gamble and drink. Better-educated men who refrained 
until they entered college found themselves “out of it” if they didn’t 
light up. Sociability was tobacco’s most seductive attraction, and 
its social utility made it that much harder to quit. Worse, tobacco’s 
use scandalized others and tempted them to follow the same path 
to intoxication. “The very openness and permissibility of the vice,” 
Towns decided, made tobacco the worst of the drug habits (Towns 
1915, 172).
When Towns wrote those words the first ATOD paradigm 
was near—actually, just past—its zenith. As John Burnham and 
Caroline Acker have shown, beliefs about the pathological links 
among drugs and other vices had yielded practical political conse-
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quences in the broad-gauge progressive campaign against the urban 
“vice constellation.” The same reformers who went after narcotics 
and alcohol often tried to suppress cigarettes, prostitution, pornog-
raphy, and gambling. Essentially, they understood vice as a package 
deal (Burnham 1993; Acker 2002).
Even in the 1910s, however, forces were emerging that would spell 
the end of the first inebriety movement. In fact, by the late 1930s, the 
idea of biosocial linkages among alcohol, tobacco, and other drugs 
had all but disappeared. True, it persisted in otherwise disparate 
groups that shared an unremitting ideological hostility to all 
psychoactive drugs. Nazis, Mormons, and Evangelical Protestants 
come to mind. Total sobriety makes for strange bedfellows. But 
in both western medicine and in western popular culture, alcohol 
and tobacco effectively split off from other drugs, to the point that 
the ordinary understanding of the word “drugs” came to exclude, 
rather than include, these substances. Anyone who asked North 
American high school students in the 1940s what “drugs” meant 
would have been told they had something to do with hospitals or 
dope fiends. Why did this happen?
The collapse of the unifying inebriety theory is a good place to 
begin. Briefly, its proponents never delivered the scientific goods. 
They never showed, at the level of cellular pathology, the common 
mechanism by which drugs caused lasting neurological damage 
in susceptible persons, or caused such symptoms as withdrawal 
and craving. The few specific hypotheses, such as Ernest Bishop’s 
antitoxin analogy, were falsified. No one ever discovered the 
mechanism by which alcohol and other drugs damaged germ plasm. 
The Lysenko episode aside, belief in Lamarckian ideas collapsed. 
Western researchers abandoned the assumption that acquired traits 
could be passed on to offspring. The Nazi horrors and abuses such 
as involuntary sterilization gave eugenics a bad name. Researchers 
quit generalizing about alcohol as a “race poison,” or generalizing 
much about races at all.
What midcentury researchers did do, with the support of both 
Alcoholics Anonymous and the alcoholic beverage industry, was to 
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focus on alcoholism. Howard Haggard and E. M. Jellinek’s widely 
read 1942 book, Alcohol Explored, exemplified the new approach. 
Alcoholism was still a disease, to be sure, but a specific disease 
manifest in a minority of users who could not control their drinking. 
Alcohol itself was not inherently toxic. The authors found no 
evidence that alcohol damaged offspring, either through heredity 
or teratogenesis. Indeed, for the majority of drinkers, alcohol was 
merely a harmless “social condiment.” The old inebriety view of 
alcohol—in Norman Kerr’s words, that it was a “poisonous narcotic 
beverage”—now seemed passé (Roizen 2004; Haggard and Jellinek 
1942, 12, 208; Kerr 1887, 2). 
The widespread social use of alcohol by physicians and their 
spouses could only have made these new views more congenial. The 
same may be said of tobacco. The now-infamous Camel claim, that 
doctors smoked Camels more than any other brand, was false. But 
the deeper premise—that doctors smoked a lot of cigarettes, at least 
before the first big cancer scare in the 1950s—was true. Personal use 
tended to blind physicians and researchers to the harms of tobacco 
and to its links to other patterns of drug use.
 They weren’t alone. As millions of ordinary men and women 
took up cigarettes, the idea that smoking necessarily led to intox-
icating drugs faded. Many of the new smokers were patriotic 
veterans of the Great War, and they had received their cigarettes 
from reputable organizations like the Red Cross (Tate 1999). 
Airplane pilots even dropped cigarettes to doughboys in advanced 
posts. A few years ago, working in the Library of Congress, I found 
a gouache drawing with the unlikely title “Colonel Sir Valtravers 
Plantagenet gladly accepts a light, during a slight lull in the barrage, 
from a private in the Benin Rifles” (Figure 2). I proposed the illus-
tration for Forces of Habit, only to have one of my editors veto it. 
She said it played on racial stereotypes. It certainly did, but that’s 
why I thought it worked. It made my point that cigarettes had tran-
scended the conventional social boundaries of race and class. Only 
the barrier of gender remained, and that gave way in the 1920s and 
1930s, thanks to clever advertising and the influence of the movies.
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In the late 1930s, 1940s, and 1950s, cigarette smoking among 
adults became so widespread as to be unremarkable, unexception-
Figure 2. Gouache drawing in the Library of Congress: “Colonel Sir 
Valtravers Plantagenet gladly accepts a light, during a slight lull in the 
barrage, from a private in the Benin Rifles.”
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able, socially invisible. Smoking paraphernalia spread everywhere. 
Ash trays sprouted on bistro tables and soda-fountain counter tops, 
cigarette lighters appeared on car dash boards, and, if you wanted 
to make a statement, you could even buy your own ring-cigarette 
holder. Matchbooks, which doubled as a convenient form of adver-
tising, were the most common sort of paraphernalia. Their covers 
show how culturally Janus-faced smoking had become. Some of 
them already nod back in the direction of the underworld, the 
adult world of risqué jokes and taverns and extra-marital sex. But 
there’s also the shining upperworld of modernity: nationalism, fast 
transportation, electrified communication, and consumer conve-
niences. Smoking is up-to-date and linked to two other kinds of 
licit drugs, alcoholic and caffeinated beverages. Matchcovers even 
pitched products designed to ameliorate the consequences of 
smoking, such as cough drops—an aspect of a broad phenomenon 
that economists call “externalities” and I call “problem profits.”
Both the masses and elites smoked. Elite smoking habits were so 
well known that cartoonists could use them as shorthand, identifying 
Winston Churchill by his long cigar, FDR by his cigarette holder, 
and Douglas MacArthur by his corncob pipe. Such personal use 
of tobacco had nothing to do with “real” drugs. Indeed, pamphlets 
at the Lexington Narcotic Hospital told new patients where to buy 
their smokes. Clouds of smoke hung over AA meetings. By contrast, 
the Keeley Institute had refused to accept cigarette smokers. The 
late-nineteenth-century view was that they had slipped into the use 
of alcohol and narcotics easily, and that, while they smoked ciga-
rettes, they could not abstain from other drugs.
The decoupling of alcohol and tobacco from other drugs was no 
accident. It was at least partly the result of a deliberate campaign 
by powerful and fiscally important industries, which spent millions 
on advertising and public relations to promote and defend their 
products. These industries had a huge advantage. Ethical pharma-
ceutical manufacturers couldn’t advertise drugs like narcotics or 
stimulants, except within relatively narrow professional medical 
circles. Folk or bohemian drugs like marijuana spread by word of 
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mouth. Virtually the only advertising they generated was official 
warnings aimed at discouraging their use. Makers of alcohol and 
tobacco, however, were free to present their products as innocent 
and salubrious, and to do so to a mass audience. Guinness famously 
reduced the message to a slogan: “Guinness is good for you.”
Abetted by the movies, alcohol and tobacco ads played up 
themes of youth, glamor, athleticism, and conviviality. True, the 
manufacturers could never fully escape or suppress the evidence 
of their products’ toxicity and addictive potential. But they could 
hire public relations experts to counter unwelcome news. Hill and 
Knowlton, America’s leading public relations firm, worked for both 
the Licensed Beverages Industries, Inc., and the cigarette manufac-
turers. Hill and Knowlton managed the Tobacco Industry Research 
Committee, a public relations operation intended to assuage public 
anxieties by raising doubts about the cancer link and fostering the 
impression that the industry was actively investigating any potential 
health problems. The British industry created a comparable orga-
nization. It challenged purely statistical studies and called attention 
to the industry’s funding of lung-cancer research. The implicit 
message: if there’s something bad in cigarettes, the scientists in the 
white coats will find it and take it out, so relax and carry on smoking 
(Courtwright 2005).
Of course, there were plenty of honest researchers in the mid-
twentieth-century, researchers who operated independently of the 
tobacco and alcoholic beverage industries. But they all faced the 
problem of information glut. Another, quotidian reason that the 
first ATOD paradigm unraveled was specialization. To cope with 
the literature explosion, researchers had to concentrate on one 
drug, or one aspect of one drug. I suspect everyone here has come 
up against this problem. When I began my dissertation on opiate 
addiction, I found an international bibliography, The Pharmacology 
of the Opium Alkaloids (Krueger, Eddy, and Sumwalt, 1943), that 
was full of clinical, epidemiological, and pharmacological material. 
Too full: there were nearly 10,000 entries. I remember thinking, 
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“They’ve got to be kidding.” Any notion of studying more than one 
type of drug in one country quickly departed.
I sank my particular posthole in the mid-1970s and dug in it 
contentedly for some time. Looking back over thirty years, I’d say 
the biggest surprise has been the rebirth of inebriety. It doesn’t go 
by that name, or any single name. It’s been called chemical depen-
dency, substance abuse, and ATOD abuse, among other terms. 
But there’s no mistaking its presence. Bill White, a clinician and 
historian, said it best in Slaying the Dragon. “For most of the 20th 
century,” White wrote, “no conceptual umbrella existed to help the 
field understand and intervene in the destructive use of all psycho-
active drugs. The most seminal event in the modern era of addiction 
treatment was the reformulation of terms analogous to the earlier 
concept of inebriety.” Researchers and clinicians rethought the 
addiction experience, emphasizing its commonalities and looking 
for integrated theories and treatment approaches. The same 
conceptual shift, White argued, was linked to the “culture’s more 
temperate relationship with alcohol and its growing rejection of 
tobacco” (White 1998, 287-88).
So attitudes toward ATOD have swerved backed to the other 
side of the road. The big increases in youthful and polydrug abuse 
undoubtedly had much to do with this switch. So did the growing 
western cultural awareness of, and aversion to, health risks of any 
variety. But I want to highlight three “internalist” factors: discov-
eries in neuroscience, genetics, and new epidemiological findings.
Since the 1960s, scientists have worked out, in increasingly refined 
detail, how psychoactive drugs affected the mesolimbic dopamine 
system. This is the neural reward pathway that originates in the 
ventral tegmental area at the base of the brain. From this region 
the neurotransmitter dopamine carries messages forward to the 
nucleus accumbens, a key pleasure center beneath the frontal cortex. 
Experiments on animals that have been taught to self-administer 
drugs have shown a sure-fire method for eliminating addiction: just 
destroy this system. Of course, there are minor drawbacks, like loss 
of interest in food. That’s why drug addiction is so stubborn and 
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insidious. It represents, at least on one level, the chemical hijacking 
of the brain’s most basic and ancient system of reward and motiva-
tion.
 There’s more to the story than a single neural pathway. Drug 
administration also sends messages to the amygdala and hippo-
campus, which are important for forming memories and cues 
associated with craving and relapse. It’s also true that drugs work 
in different ways. Opiates and alcohol stimulate dopamine produc-
tion directly, while cocaine blocks its reuptake. But the bottom line, 
to quote a recent literature review, is “different drugs, same ultimate 
effect” (Nestler and Malenka 2004, 84). That goes for licit and illicit 
drugs, and sometimes for licit and illicit drug treatment. Naltrexone, 
an antagonist that blocks opioid receptors and which has been used 
to treat narcotic addicts, has shown promising results in preventing 
craving and relapse among alcoholics (Rawson et al. 2000). Though 
the degree of Naltrexone’s therapeutic benefit is still under inves-
tigation, and though it may not help the severest alcoholics (e.g., 
Krystal et al. 2001), the findings do suggest that at least some of 
the opioid receptors are involved in both types of addiction. Also 
intriguing is the fact that PET brain scans of compulsive gamblers 
shown slot machines look very similar to those of cocaine addicts 
shown white lines on a mirror. Compulsive gambling and drug 
addiction have many symptomatic parallels, and there is a good 
deal of comorbidity: heavy gamblers are more likely to be ATOD 
users, and vice versa (Petry 2002).
That’s not to say that all forms of addiction can be reduced to a 
single neural pathway, or that drug use can be understood apart 
from its social and cultural context. When critics (e.g., Satel 2002) 
accuse the National Institute on Drug Abuse of being obsessed with 
the “chronic relapsing brain disease model,” to the exclusion of 
other approaches, they make a fair point. Even Alan Leshner, the 
former head of NIDA who did so much to popularize the neuro-
logical model, wrote that “addiction is not just a brain disease. It 
is a brain disease for which the social contexts in which it has both 
developed and is expressed are critically important” (Leshner 1997, 
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46). Still, one does not have to be a biological reductionist to grasp 
the historical significance of this research trend or to understand 
how it reinforces the idea that psychoactive drugs have more in 
common than was once thought. The progressives had a point. 
Vices are linked.
The predisposition toward vice may also have a genetic basis, if not 
necessarily a Lamarckian one based on our ancestors’ poisonously 
altered germ plasm or otherwise wickedly acquired characteristics. 
“Several twin studies,” to quote a recent JAMA review, have shown 
“significantly higher rates of dependence among twins than among 
nontwin siblings and higher rates among monozygotic [identical] 
than dizygotic [nonidentical] twins.” Heritability measures have 
been estimated at 0.34 for men dependent on heroin, 0.55 for men 
dependent on alcohol, 0.52 for women dependent on marijuana, 
and 0.61 for men and women who are regular cigarette smokers 
(McLellan et al. 2001). The inebriety theorists’ hunch, that individual 
reactions to alcohol, tobacco, and other drugs vary, depending on 
innate neurological susceptibility and family history, have appar-
ently been borne out for several different substances. Some people 
are disposed to find certain kinds of drug use more rewarding, or 
less toxic, or both. Addictive predispositions may overlap. Studies 
have shown that those with a genetic predisposition for alcohol 
dependence are also more likely to have problems with patholog-
ical gambling (Petry 2002, 185).
It is possible that the correlations are due, not so much to neuro-
logical susceptibility per se, but to personality traits that are also 
partially inherited. Children, especially male children, who lack 
self-control and future orientation, who are impulsive, insensi-
tive to others, and less intelligent, are more likely to experiment 
with drugs. In fact, this same constellation of traits predicts a wide 
range of illegal behaviors (Gottfredson and Hirschi 1990). Loutish 
thrill-seekers will end up with more ATOD problems for the same 
reason they end up with more jail time for smash-and-grab thefts 
and joyriding in stolen cars. Personality traits increase the odds 
of forbidden experimentation, and experimentation increases the 
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odds of (indeed, is a prerequisite for) long-term conditions like 
addiction.
Having said this, I should add that I’ve long had reservations 
about the concept of an “addictive personality,” whether defined in 
terms of neurological susceptibility or broader antisocial behavior. 
If personality is so important, why were most American opiate 
users middle-aged, middle-class females in the nineteenth century 
and younger, lower class-men in the twentieth? Or why were they 
once mostly white and Asian and, then, within the space of two 
or three decades in the mid-twentieth century, mostly black and 
Hispanic? Were the addictive personality traits “jumping genes” 
that hopped from one group to another? (Courtwright 2001a, 6, 
152-55). Obviously, specific social circumstances—what doctors 
prescribed, which immigrants were moving into drug-infested 
slums—mattered a great deal. One might even say that it is the 
historian’s indispensable task to point out what those specific 
circumstances were, and how they changed over time. That said, 
the question of inherited vulnerability has clearly reemerged in the 
addiction research field; it has important implications for etiology, 
prevention, destigmatization, and treatment; and it has reinforced 
the idea that a range of compulsive behaviors may have common 
biological elements.1
The third field that has contributed to the rebirth of the ATOD 
paradigm has been epidemiology. Even allowing for some bene-
ficial cardiovascular effects from moderate wine drinking, 
statisticians documented, with increasing precision, the elevated 
risks of accidents when drinking, and the risks of chronic disease 
for heavy drinkers. The more one drank, the greater the risks—a 
dose-response finding central to the emergence of the alcohol 
public-health paradigm in the mid-1970s (Roizen 2004; Room 
2004). The smoking data were even more damning. The relent-
less accumulation of health evidence, and the related economic 
evidence of heavier health-care costs, undercut the efforts of alcohol 
and tobacco companies to portray their products as benign non-
drugs. It also explains why these same companies have increasingly 
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sought to exploit markets in developing countries, where govern-
ment regulations are fewer and consumers tend to be less wary.
In the mid-1970s, Denise Kandel and others put the gateway 
theory on a much firmer epidemiological basis. They emphasized 
the risk of advancing from licit to illicit drugs. Not all smokers or 
drinkers did so, but their odds of progression were far higher than 
abstainers’—a finding that held up in France, Israel, and Japan as 
well. As a recent RAND study shows, adolescent smokers were at 
especially high risk (Kandel 2002; Ellickson 2002). The same study 
showed early smoking to be an excellent predictor of subsequent 
social problems. When the politician and novelist Jeffrey Archer 
was sent to Belmarsh prison following his 2001 perjury conviction, 
practically the first thing he noticed was the ubiquity of smoking. 
It took only a few strip searches before it dawned on him that the 
inmates, especially the repeat offenders, were also heavily involved 
in the illicit drug culture (Archer 2003).
The process by which young smokers moved on to other drugs 
involved three types of causes—social, learning, and neurochemical. 
None was necessary or sufficient, but all increased the likelihood of 
other drug use. Socially, “enabling factors” played a key role. These 
were the influences Charles Towns had in mind when he described 
boys lighting up in the pool hall. Adolescent smokers were more 
likely to be part of peer groups in which alcohol and other drugs 
were available. They were more likely to become curious about 
them, to observe how they were used, and to receive praise if they 
tried them for themselves. Ditto other problem behavior, such as 
petty theft or skipping school. 
Learning also played a part. Smoking is an acquired skill, 
something neither intuitive nor pleasant on first trial. By learning to 
inhale tobacco smoke, individuals acquired the behavior necessary 
for consuming marijuana and other smokable drugs. Because 
underage smoking was illegal, adolescent tobacco users also learned 
to develop masking behaviors that served to hide forbidden drug 
use.
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Then there is the effect of tobacco itself. Smokers have lower levels 
of monoamine oxidase-B, the enzyme responsible for breaking 
down dopamine in the brain. They can sustain higher levels of 
dopamine for longer periods of time, particularly if they continue 
smoking. More dopamine means more pleasure: tobacco works 
synergistically with alcohol, cannabis, cocaine, and narcotics to 
provide a sustained high. Hence alcohol and other drug users tend to 
smoke more heavily. The reverse is also true. Alcohol, a depressant, 
mitigates some of the adverse effects of smoking, such as increased 
heart rate. And alcohol activates nicotine-metabolizing enzymes, 
which makes it necessary to consume more tobacco to achieve the 
accustomed effect (Courtwright and Courtwright, forthcoming).2
In brief, the neuroscientific and epidemiological studies suggest 
that drug consumption is synergistic and crosses licit-illicit lines. 
I found that out for myself when I began, in the opening chapters 
of Forces of Habit, to describe when various drugs had become 
important commodities. We have all been taught that description 
is easier than analysis. I found the opposite to be true. The analytic 
chapters—how medical drugs caught on in popular culture, 
why drugs were ideal products, how drugs financed empires and 
exploited colonial labor, why elites finally imposed restrictions—
turned out to be much easier to write. The biggest challenge was 
describing the globalization of drugs, a process I called the “conflu-
ence of the world’s psychoactive resources” (Courtwright 2001b).
I thought I’d tackle one drug at a time. I’d describe the spread of 
alcoholic beverages, then tobacco, then caffeinated beverages—“the 
big three”—then move on to opiates, cannabis, coca products, and 
synthetics. Try as I might to keep my drug histories compartmental-
ized, they kept sloshing over onto one another. “Confluence” really 
is le mot juste. The Chinese, for example, learned to smoke tobacco, 
then tobacco mixed with opium, then refined opium. When early 
modern European sailors went on liberty, pipe in one hand and 
drink in the other, they instructed natives in the art of smoking and 
drinking. They taught that these two novel practices went together. 
(As, neurochemically, they in fact do.) I discovered that early 
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modern European coffee houses were seldom simply coffee houses. 
Patrons could purchase all sorts of psychoactive products, from 
chocolates to exotic liqueurs. They could also smoke, which was 
good for business, because, we now know, smokers metabolized 
caffeine much faster than nonsmokers. I also found that complex, 
overlapping patterns of consumption had developed in Europe’s 
many colonies. In 1945, when Ho Chi Minh declared Vietnamese 
independence, he condemned the French for foisting opium and
alcohol on his people. I suppose he didn’t add tobacco to the list 
because he himself was an inveterate smoker.
At the deepest level of historical connection, one might say at 
the point where economic substructure meets the reptile brain, the 
common denominator of globalized nonmedical drug use was the 
rise of limbic capitalism. By that I mean the reorientation of capi-
talist enterprise from basic services and durable goods to the more 
profitable business of providing transient but habitual pleasures, 
whether drugs or pornography or gambling or even sweet and fatty 
foods. In global terms limbic capitalism first became important in 
the age of transoceanic empire building. Were it not for the trade 
in sugar, tobacco, tea, and opium, there never would have been a 
British Empire, with all that entailed for modern history. Limbic 
capitalism has become even more conspicuous and lucrative 
in our own advanced (if that is the word) consumer societies. 
Entrepreneurs exploit evolved drives and then provide the goods 
and services to cope with the damage. Alcohol sells aspirin, 
cigarettes sell nicotine patches, sugar sells insulin, heroin sells 
Naltrexone, which costs addicted patients between $100 and $150
a month (Rawson et al. 2000). A recent book, Investing in Vice, 
concludes that the best, most recession-proof financial strategy is 
to buy a portfolio of “sin stocks,” taking advantage of their rela-
tively inflexible demand curves (Ahrens 2004). I would “double 
down” the bet by adding stocks of the companies that clean up after 
the sin companies. Logically, the demand curves for the two sorts 
of products are correlated.
   The Social History of Alcohol and Drugs 20 (2005)122
I can’t explore all the ramifications of limbic capitalism. But 
I have tried to show how biological, genetic, epidemiological, 
and historical evidence has given momentum and credibility 
to the revitalized ATOD paradigm. That doesn’t guarantee its 
permanent or universal triumph. In particular, alcohol may resist 
the trend. The alcoholic beverage industry has money, influence, 
and an argument—moderate consumption is healthful—that may 
continue to win privileges for its product. Time will tell. Invite me 
back thirty years hence, and I’ll tell you whether Mr. ATOD’s car 
has swerved back to the other side of the road.
University of North Florida
dcourtwr@unf.edu
Notes
1. For reasons of time, I omitted the section on genetics during the original talk.
2. The relationship between nicotine and caffeine is complex, but researchers 
have shown that rats chronically exposed to caffeine self-administer nicotine 
at higher-than-control levels. Compared to nonsmokers, heavy smokers prefer 
more heavily caffeinated beverages, e.g, coffee rather than tea. Other drugs 
shown to increase nicotine consumption in animals include pentobarbital, 
amphetamine, methadone, and heroin (Courtwright and Courtwright, forth-
coming). 
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Addiction Science, History, and the ATOD 
Paradigm: A Reply to Hasso Spode, Ian Tyrrell, 
and James Mills
David T. Courtwright
Hasso Spode and Ian Tyrrell are right to point out that, in a global 
perspective, the debate over addiction began earlier and assumed 
more complex forms than indicated in my sketch. It is true too that 
ideas about addiction were “culturally lagged”—a useful phrase—
and that the question of ATOD unity begged another issue, namely, 
where addiction was existentially located. So, yes, the situation a 
century ago was messier than the inebriety paradigm alone would 
indicate. Hence my circumspection in limiting the discussion 
to Britain and North America, places where the unified inebriety 
concept temporarily dominated medical opinion.
“Medical opinion” was not, as James Mills reminds us, solely the 
domain of physicians and scientists. My own lay example, Charles 
Towns, was a salesman who overcame initial skepticism from the 
medical establishment and who became, for a time, a respected 
figure in the treatment community. In Britain and North America, 
however, physicians like Norman Kerr or Thomas Crothers did 
most of the technical, etiological writing on drugs and the nervous 
system. Ultimately, it was their failure to create a testable empirical 
basis for the unified inebriety theory, to advance beyond the 
vague nineteenth-century concepts of neurasthenia, diathesis, and 
degeneration, that made the concept vulnerable to scientific and 
corporate counterattack in the mid-twentieth century.
Today the revitalized ATOD paradigm extends well beyond the 
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Anglo-American world. It has gone global, as has the scientific 
enterprise itself. On-line journals carry the latest discoveries 
about neural pathways, receptors, genetic predispositions, drug 
synergisms, and gateway epidemiology to researchers and public 
health officials around the world. Tyrrell captured the spirit of 
my essay when he suggested that historians can apply these same 
medical-scientific insights to past patterns of drug use, while 
avoiding biological reductionism by showing the play of cultural, 
geographic, and social forces.
All three commentators note that I emphasized medical research 
discoveries in explaining the rise of the new ATOD paradigm. One 
reason for doing so is that the lack of biological evidence was a key 
reason why the old inebriety paradigm collapsed. Nineteenth- and 
early twentieth-century observers saw that addictive behaviors
were like one another in important ways, such as compulsive 
use, withdrawal symptoms, craving, and relapse. Until the 1970s, 
however, no one could make neurochemical sense of why different 
substances produced similar intoxicating and addictive effects. That 
was the essential breakthrough, though external factors like growing 
concern over health risks or corporate malfeasance prepared the 
cultural soil onto which the seed of scientific insight fell.
When I wrote the lecture I knew that drug historians preferred the 
cultural soil to the scientific seed. Another reason for highlighting 
scientific advances was to bring them to the attention of an influential 
scholarly audience that seemed to be getting too comfortable in its 
social-constructionist ways. James Mills counters that “so much of 
what has gone before as authoritative data has, in fact, simply been 
morality or prejudice dressed up with the ribbons of science.” Fair 
enough. But it is also fair to say that we now know more, and in 
more fine detail, about how various drugs actually affect the brain 
than we did in the Victorian era. There is progress in science, and 
that progress can be liberating. For too long drug historians have 
been like transportation historians writing separate monographs 
on cars, trucks, and motorcycles without knowing how internal 
combustion engines worked, or why they burned hydrocarbon 
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fuels and generated pollution. Suspicion of scientific arrogance 
and imperialism ought not to prevent anyone from the selective 
appropriation of research insights, especially those that illuminate 
the common or synergistic features of drug action. My subversive 
advice: break history’s last taboo. Take a hit of neuroscience. Just 
don’t get addicted.
Tyrrell asks where the line on drugs should be drawn. My rule 
of thumb is to include any psychoactive substance that stimulates 
the mesolimbic dopamine system, the primitive neural substrate of 
pleasure and motivation. Thus cocaine and caffeine are both drugs, 
though one is good deal stronger than the other. Sugar is a special 
case. I don’t consider sugar a drug per se, but it has often been made 
into a drug (alcohol) or used to sweeten drug preparations such as 
chewing tobacco or tea. A spoonful of sugar makes the alkaloid go 
down.
If drug history evolves toward the broader study of compulsive 
behaviors, such as gambling or even certain types of eating, I would 
be neither surprised nor perturbed. Cheese may not be “morphine 
on a cracker,” as one activist has claimed, but we should remain 
open-minded about where research on the brain’s pleasure centers 
will lead. Social history is about making connections. Medical 
science keeps suggesting new connections. Is it, for example, just 
a cultural coincidence that games of chance have long flourished 
in taverns, or that Las Vegas runs on booze, or that the Koran 
prohibits both alcohol and gambling? I don’t know the answer. I 
do know that posing such questions will enrich our field, and align 
us with researchers who are expanding the boundaries of other 
disciplines.
University of North Florida
dcourtwr@unf.edu
